Evidence map›Paper›PMID 19629655›Full record

ArticleJournal of clinical immunology2009

Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency.

Javad Mohammadi, Chonghai Liu, Asghar Aghamohammadi, Astrid Bergbreiter, Likun Du, Jiayi Lu, Nima Rezaei, Ali Akbar Amirzargar, Mostafa Moin, Ulrich Salzer and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of clinical immunology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 57 citations in OpenAlex.

  1. Re-evaluation of the contribution ofJournal of human immunity · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Novel heterozygous mutations ofBlood science (Baltimore, Md.) · 2024
    Article
  8. Article
  9. Observational
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Javad MohammadiDivision of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden.
Chonghai Liu
Asghar Aghamohammadi
Astrid Bergbreiter
Likun Du
Jiayi Lu
Nima Rezaei
Ali Akbar Amirzargar
Mostafa Moin
Ulrich Salzer
Qiang Pan-Hammarström
Lennart Hammarström
Karolinska University Hospital · SEChildren's Medical Center · IRKarolinska Institutet · SEUniversity Medical Center Freiburg · DETehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCommon variable immunodeficiency (CVID) is a heterogeneous syndrome characterized by impaired immunoglobulin production. The disorder is also characterized by co-occurrence of autoimmune, lymphoproliferative, and granulomatous diseases. Mutations in the gene encoding TACI (Transmembrane Activator and CAML Interactor, TNFRSF13B) were previously found to be associated with CVID. MATERIALS AND

methodsWe therefore sequenced TNFRSF13B gene in a cohort of 48 Iranian CVID patients. Expression of TACI and binding of A proliferation-inducing ligand (APRIL) were tested by FACS.

resultsWe identified one patient with a homozygous G to T substitution in the TNFRSF13B gene at the splice site of intron 1 (c.61+1G>T), which abolished expression of the TACI molecule and binding capacity of APRIL. This represents the second CVID patient in the world with a complete absence of TACI expression. B cell lines from family members carrying the same mutation in a heterozygous form showed a reduced level of TACI expression and APRIL-binding capacity, suggesting a gene dosage effect. In addition, we found the previously recognized C104R and C172Y mutations in a heterozygous form in two patients with CVID and one, novel, heterozygous P42T mutation.

conclusionTACI mutations were observed in Iran CVID patients in a similar frequency as in other Caucasian populations. The novel mutations identified in this study support the notion of a crucial role for TACI in B cell differentiation.

Indexed as

MutationB-LymphocytesCell DifferentiationCohort StudiesCommon Variable ImmunodeficiencyFamily HealthFemaleGene DosageHomozygoteHumansIranMalePedigreeProtein BindingTransmembrane Activator and CAML Interactor ProteinTumor Necrosis Factor Ligand Superfamily Member 13TNFRSF13B protein, humanTransmembrane Activator and CAML Interactor ProteinTumor Necrosis Factor Ligand Superfamily Member 13

Identifiers

PMID19629655
OpenAlexW2040868347

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.